ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunton, R. W.
Right arrow Articles by Borrie, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunton, R. W.
Right arrow Articles by Borrie, J.

Ann Thorac Surg 1982;33:609-613
© 1982 The Society of Thoracic Surgeons

Articles

Pleural Fibromas: A Clinical Review and Report of Six Patients

R.W. Bunton, M.B., Ch.B.*, J. Borrie, Ch.M., F.R.C.S., F.R.A.C.S.

From the Thoracic Surgical Unit, Dunedin Hospital, and the Department of Surgery, University of Otago Medical School, Dunedin, New Zealand

Accepted for publication October 13, 1981.

* Address reprint requests to Dr. Bunton, Department of Surgery, University of Otago Medical School, P.O. Box 913, Dunedin, New Zealand

Localized pleural fibromas are a definite clinical entity. Their origin is much debated. Though most arise from the mesothelial cell, occasionally some arise from the pleural fibroblast. The former retain the potential to become malignant. Distinguishing between the two origins can aid prognosis after treatment. The characteristic cell is a spindle-shaped fibroblast. Slits or clefts lined by flattened cells are often present in the tumor.

Clinically, pleural fibromas are usually asymptomatic, space-occupying lesions. Chest symptoms are nonspecific. Extrathoracic symptoms, especially arthritis, are not uncommon and occur only in the benign variety.

Excision is the treatment of choice, but long-term follow-up is essential, for recurrence is not unknown and is often heralded by the return of arthritic symptoms. Recurrences may be benign or malignant, the latter having a poor prognosis, with most patients dying within 2 years. Experience with benign pleural fibromas seen in 6 patients over a 25-year period is presented.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.